Faculty, Staff and Student Publications

Authors

    Language

    English

    Publication Date

    9-19-2024

    Journal

    Human Molecular Genetics

    DOI

    10.1093/hmg/ddae109

    PMID

    39017605

    PMCID

    PMC11413647

    PubMedCentral® Posted Date

    7-17-2024

    PubMedCentral® Full Text Version

    Post-print

    Abstract

    Disease risk prediction based on genomic sequence and transcriptional profile can improve disease screening and prevention. Despite identifying many disease-associated DNA variants, distinguishing deleterious non-coding DNA variations remains poor for most common diseases. In this study, we designed in vitro experiments to uncover the significance of occupancy and competitive binding between P53 and cMYC on common target genes. Analyzing publicly available ChIP-seq data for P53 and cMYC in embryonic stem cells showed that ~344-366 regions are co-occupied, and on average, two cis-overlapping motifs (CisOMs) per region were identified, suggesting that co-occupancy is evolutionarily conserved. Using U2OS and Raji cells untreated and treated with doxorubicin to increase P53 protein level while potentially reducing cMYC level, ChIP-seq analysis illustrated that around 16 to 922 genomic regions were co-occupied by P53 and cMYC, and substitutions of cMYC signals by P53 were detected post doxorubicin treatment. Around 187 expressed genes near co-occupied regions were altered at mRNA level according to RNA-seq data analysis. We utilized a computational motif-matching approach to illustrate that changes in predicted P53 binding affinity in CisOMs of co-occupied elements significantly correlate with alterations in reporter gene expression. We performed a similar analysis using SNPs mapped in CisOMs for P53 and cMYC from ChIP-seq data, and expression of target genes from GTEx portal. We found significant correlation between change in cMYC-motif binding affinity in CisOMs and altered expression. Our study brings us closer to developing a generally applicable approach to filter etiological non-coding variations associated with common diseases.

    Keywords

    Humans, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Polymorphism, Single Nucleotide, Doxorubicin, Binding Sites, Protein Binding, Cell Line, Tumor, non-coding DNA variants, tumor suppressor, proto-oncogene, computational modeling, Cis-overlapping motifs

    Published Open-Access

    yes

    Included in

    Dentistry Commons

    Share

    COinS
     
     

    To view the content in your browser, please download Adobe Reader or, alternately,
    you may Download the file to your hard drive.

    NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.